GT Biopharma, Inc. (GTBP) vs Phio Pharmaceuticals Corp. (PHIO)
- GT Biopharma, Inc. GTBP 4.71 −2.69%
- Phio Pharmaceuticals Corp. PHIO 0.80 −8.05%
GT Biopharma, Inc. and Phio Pharmaceuticals Corp. are both Biotechnology companies. GT Biopharma, Inc. and Phio Pharmaceuticals Corp. are of similar size ($9.4M and $9.3M). Phio Pharmaceuticals Corp. has negative trailing earnings, so its P/E is not meaningful; GT Biopharma, Inc. trades at 0.8×. Phio Pharmaceuticals Corp. grew revenue faster over the last twelve months: 79.0% against −76.2%. Across the 13 metrics below, Phio Pharmaceuticals Corp. leads on 8 and GT Biopharma, Inc. on 5.
Valuation
Profitability
| Metric | GTBP | PHIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 41.67% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 102.03% | (113.71%) | (50.12%) |
| Return on assets | (176.27%) | (100.78%) | (45.60%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack